SFS
PJP icon

Signator Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Signator Financial Services’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$6K Hold
135
– – 0.01% 231
2013
Q2 		$6K Buy
+135
New +$5.62K 0.01% 227

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PFG
Pacific Financial Group Bellevue, Washington $186M AUM 16.59% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Signator Financial Services's PJP Position: Q3 2013 in Review

Signator Financial Services held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2013 at 135 shares worth $6K. The position accounts for 0.01% of the portfolio, ranked #231.

Signator Financial Services first reported a position in PJP in Q2 2013 and has held it in 2 quarters since. 69 funds tracked by Wall St. Rank hold PJP as of Q3 2013.

  • Signator Financial Services held 135 shares of Invesco Pharmaceuticals ETF worth $6K as of Q3 2013.
  • Signator Financial Services left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2013.
  • Invesco Pharmaceuticals ETF made up 0.01% of Signator Financial Services's portfolio in Q3 2013, its #231 holding.
  • Signator Financial Services first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 2 quarters since.
  • 69 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2013.

Based on Signator Financial Services's 13F filing for Q3 2013, filed 25 Aug 2014.